End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.2 SEK | -1.34% | +1.61% | +32.34% |
22/04 | EQL Pharma AB Announces Mellozzan Launched in Germany and Austria | CI |
13/02 | EQL Pharma AB Provides Sales Guidance for the Year 2023/24 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.34% | 119M | |
-33.90% | 14.89B | |
-25.06% | 12.2B | |
-28.07% | 6.54B | |
+13.39% | 6.37B | |
-9.19% | 6.03B | |
-0.44% | 4.73B | |
+59.80% | 4.57B | |
-9.15% | 3.82B | |
-10.72% | 3.51B |
- Stock Market
- Equities
- EQL Stock
- News EQL Pharma AB
- EQL Pharma : Receives Regulatory Approval for Nausea, Vomiting Treatment in Sweden